4 Results for "

STT3A/B

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "STT3A/B" in MCE Product Catalog:

21
21 Cited Publications
Cat. No.: HY-117383
CAS No.: 790702-57-7
Purity:  99.97%
Synonyms: ML414
Target:  

Virus Protease

Research Areas:  

Cancer

NGI-1 (ML414) is a potent oligosaccharyltransferase (OST) inhibitor, directly targeting and blocking the function of the OST catalytic subunits STT3A and STT3B . NGI-1 is a cell permeable inhibitor and can effectively reduce virus infectivity without affecting cell viability .
loading...
    loading...
Cat. No.: HY-169003
CAS No.: 3067184-99-7
Target:  

Virus Protease

Research Areas:  

Infection Neurological Disease Cancer

STT3A/B-IN-1 is an orally active STT3A/B inhibitor with antiviral activity. STT3A/B-IN-1 upregulates DERL3 gene expression levels. STT3A/B-IN-1 is promising for research of viral diseases, including cancer and neurodegenerative disorders .
loading...
    loading...
Cat. No.: HY-176433
CAS No.: 79514-43-5
Target:  

Flavivirus

Research Areas:  

Infection

NSC-323241 is a potent STT3A-mediated mega protein complex assembly inhibitor. NSC-323241 disrupts he endoplasmic reticulum (ER) mega complex nucleated by STT3A during dengue virus (DENV) and Zika virus (ZIKV) infection. NSC-323241 targets the binding of STT3A subcomplex with viral nonstructural proteins (e.g., NS2B, NS3) and host translocon proteins, disrupting the formation of viral replication microenvironment. NSC-323241 is promising for research of flavivirus infection, such as dengue fever and Zika virus .
loading...
    loading...
Cat. No.: HY-169003A
CAS No.: 3067185-00-3
(R,S)-STT3A/B-IN-1 (compound 32), the racemate of STT3A/B-IN-1 (HY-16900), is a STT3A/B inhibitor. (R,S)-STT3A/B-IN-1 inhibits N-Glycosylation. (R,S)-STT3A/B-IN-1 is promising for research of viral diseases, including cancer and neurodegenerative disorders .
loading...
    loading...